Equities

MaxCyte Inc

MXCT:LSE

MaxCyte Inc

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)297.00
  • Today's Change2.00 / 0.68%
  • Shares traded2.49k
  • 1 Year change-22.86%
  • Beta--
Data delayed at least 20 minutes, as of May 02 2024 17:07 BST.
More ▼

Forecasts data is unavailable for this security.

Consensus recommendation

  • 18-May-23
  • 15-Feb-24
  • 14-Mar-24
  • 18-Apr-24
  • 25-Apr-24
Select bar for recommendation details.
Recommendations25-Apr-24
Buy3
Outperform2
Hold0
Underperform0
Sell0

Share price forecast

The one analyst offering a 12 month price target expects MaxCyte Inc share price to rise to 762.36 in the next year from the last price of 297.00.
High156.7%762.36
Med156.7%762.36
Low156.7%762.36

Earnings history & estimates

MaxCyte Inc reported annual 2023 losses of -0.37 per share on Mar 12, 2024.
Average growth rate-16.96%
More ▼

Revenue history & estimates

-32768 had revenues for the full year 2023 of 41.29m. This was 6.72% below the prior year's results.
Average growth rate+18.61%
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.